We would like to share with you some highlights in Breast Cancer Research from January and February. For the full list of articles published in Breast Cancer Research, please visit the journal website.
Antonio Musolino et al. report that a potent fibroblast growth factor receptor (FGFR) inhibitor known as dovitinib demonstrated antitumor activity in pretreated patients with FGFR pathway-amplified breast cancer.
Citing results from a large nested case-control study conducted through a national screening program, Merete Ellingjord-Dale et al. suggest that reproductive factors were associated with all molecular subtypes of breast cancer to some extent, with the strongest trends being found in luminal-like subtypes.